Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes

The Journal of Experimental Medicine(2025)10.1084/jem.20250693Source: DataRank Database

Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes is a research paper published in The Journal of Experimental Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.05)OA: hybridTopics (56)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Harald Hartweger ORCID,Yoshiaki Nishimura ORCID,Edem Gavor ORCID,Kaito Nagashima ORCID,Nicholas Koranda ORCID

Live enrichment

PubMed:40794027 PMC:PMC12341506 OpenAlex:https://openalex.org/W4413109350

National Institute of Allergy and Infectious Diseases

Grant: HIVRAD P01AI100148

Bill and Melinda Gates Foundation

Grant: INV-002143

NIAID NIH HHS

Grant: P01 AI100148

NIAID NIH HHS

Grant: U54 AI170856

National Institutes of Health

Grant: 5P01AI100148-08

Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies

National Institutes of Health

NIH HHS

FWCI

3.05

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://rupress.org/jem/article-pdf/222/10/e20250693/1948692/jem_20250693.pdf

publisherhttps://rupress.org/jem/article-pdf/222/10/e20250693/1948692/jem_20250693.pdf

publisherhttps://rupress.org/jem/article-pdf/doi/10.1084/jem.20250693/1948692/jem_20250693.pdf

journalhttps://doi.org/10.1084/jem.20250693

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40794027

Fields of Study

HIV Research and Treatmentvaccines and immunoinformatics approachesImmunotherapy and Immune Responses0301 basic medicine03 medical and health sciencesAIDS VaccinesHIV-1AnimalsEpitopesHIV AntibodiesMacaca mulattaAntibodies, NeutralizingMiceHumansenv Gene Products, Human Immunodeficiency VirusHIV InfectionsFemale

MeSH Terms

AnimalsEpitopesFemaleHumansMacaca mulattaHIV AntibodiesHIV-1HIV InfectionsAIDS VaccinesMiceenv Gene Products, Human Immunodeficiency VirusAntibodies, Neutralizing

Keywords

EpitopeImmunogenHIV vaccineVirologyAIDS VaccinesGermlineBiologyAntibodyComputational biologyImmunologyHuman immunodeficiency virus (HIV)Monoclonal antibodyVaccine trialGeneticsGeneenv Gene Products, Human Immunodeficiency VirusHIV InfectionsHIV AntibodiesMacaca mulattaAntibodies, NeutralizingArticleEpitopesMiceHIV-1AnimalsHumansFemale

Sustainable Development Goals

SDG 0: Good health and well-being